For the 34 million Americans living with diabetes, this FDA clearance of the latest version of FreeStyle Libre portfolio is another life-changing experience.
Our revolutionary system builds on its long standard of eliminating the hurdles of traditional glucose monitoring and requiring no routine fingersticks9 — all at significantly lower costs than other CGMs.7
It’s exactly what you expect from a world leading health technology that’s helping people live their best lives.
Around the globe, more than 2 million people are using the FreeStyle Libre system in 50 countries.10 It has been clinically proven to be accurate, stable and consistent.
How does continuous glucose monitoring with the FreeStyle Libre 2 System work?
The FreeStyle Libre 2 system measures glucose levels through a small sensor — the size of two stacked quarters — applied to the back of your upper arm. It provides glucose readings every minute with unsurpassed 14-day accuracy, day and night11, the longest-lasting self-applied iCGM currently available. The sensor can also read glucose levels through clothes,12 making testing discreet and convenient.
The FreeStyle Libre 2 system provides three critical pieces of data with each scan:
- Current glucose level.
- An eight-hour historical trend.
- A directional trend arrow showing where glucose levels are headed.
The touch-screen reader also holds up to 90 days of data, which allows people to track their glucose levels over time.
How does the FreeStyle Libre 2 System help improve treatment?
The data generated by the FreeStyle Libre 2 system is designed to provide actionable trends and patterns that help you make better decisions about your health, such as adjustments to your diet or how much insulin you need to take. For example, the reader's snapshots can reveal if a person is experiencing hypoglycemic trends (low glucose levels) patterns or hyperglycemic trends (high glucose levels), which can aid in choosing the right diabetes management.
Studies show that FreeStyle Libre technology users who scan more frequently spend less time in hypoglycemia and experience improved average glucose levels.13,14 According to a study presented at the Advanced Technologies & Treatments for Diabetes (ATTD) meeting earlier this year in Madrid, people with type 2 diabetes on insulin using the FreeStyle Libre technology saw average HbA1c levels drop significantly.15
Go play, kids. Rest easier, parents. Diabetes doesn't have to control you. FreeStyle Libre 2 will sound the alarm16 if there’s anything to worry about. It's time to live.
1FreeStyle Libre 2 User Guide.
2Participating pharmacies are subject to change without notice. Product availability may vary by retailer.
3Based on FDA iCGM special controls.
4Data on file. Abbott Diabetes Care.
5Dexcom G6 CGM User Guide.
6Based on a comparison to Dexcom G6.
7Based on a comparison of list prices of the FreeStyle Libre 14 day system versus competitors' CGM systems. FreeStyle Libre 2 system will be list priced the same rate as FreeStyle Libre 14 day system. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
8FreeStyle Libre 2 system user manual. Dexcom G6 CGM User Guide. Based on low glucose alarms set at 70 mg/dl. for pediatrics.
9Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.
10Data on file, Abbott Diabetes Care.
11Based on the sensor being replaced once every 14 days, and scanned at least once every 8 hours.
12The reader can scan through clothing with a thickness of 1-4 cm.
13Canadian real-world analysis of flash glucose monitoring and glycemic control. Presented at the 12th Advanced Technologies & Treatments for Diabetes (ATTD) in Berlin, Germany, Lori Berard, Laura Brandner
14Acute diabetes complications defined by hypoglycemia, hypoglycemic coma, hyperglycemia, ketoacidosis, or hyperosmolarity ICD-10 codes as primary diagnosis for inpatient or as any position in the outpatient emergency claim. Presented at the 12th Advanced Technologies & Treatments for Diabetes (ATTD) in Berlin, Germany. Matthew Kerr, Gregory Roberts, Diana Souto, Yelena Nabutovsky
15Improving HbA1c control in people with Type 1 or Type 2 diabetes using flash glucose monitoring: a retrospective observational analysis in two German centers; Gerhard Klausmann, Ludger Rose. Presented at the 12th Advanced Technologies & Treatments for Diabetes (ATTD) in Berlin, Germany. Alexander Seibold
16Notifications will only be received when alarms are turned on and the sensor is within 20 feet of the reading device.
FOLLOW ABBOTT